TD Cowen Reaffirms Their Buy Rating on Amicus (FOLD)
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Amicus (FOLD – Research Report), with a price target of $20.00.
Merck downgraded to Hold from Buy at TD Cowen
TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with ...
TD Cowen cuts Merck stock to hold on uncertainty around Keytruda, Gardasil
TD Cowen downgraded Merck & Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of exclusivity for ...
Repligen started at buy by TD Cowen, limited NIH exposure cited
TD Cowen has started coverage of Repligen (NASDAQ:RGEN) with a buy rating, citing the company's limited exposure to NIH funding cuts and China. The investment bank said Repligen (NASDAQ:RGEN) was ...